**Question:** Hrischsprung disease, marker - used for early diagnosis?

A. Chromogranin A
B. Chymusin
C. Cholinesterase
D. Serotonin

**Core Concept:**
Hirschsprung disease (HD) is a congenital gastrointestinal disorder characterized by the absence of ganglion cells in the distal colon, leading to impaired transit of fecal matter and resulting in constipation and megacolon. Early diagnosis is crucial to guide treatment and improve patient outcomes.

**Why the Correct Answer is Right:**
A. Chromogranin A (CgA) is a useful marker for Hirschsprung disease diagnosis. It is a protein secreted by neural crest-derived enteroendocrine cells, which are reduced or absent in the aganglionic segment of the colon in HD patients. Elevated serum CgA levels can indicate the presence of aganglionic colon, enabling early diagnosis and timely intervention.

**Why Each Wrong Option is Incorrect:**
B. Chymusin (chymotrypsinogen) is an enzyme involved in protein digestion, not a marker for Hirschsprung disease diagnosis.
C. Cholinesterase is a group of enzymes involved in the breakdown of acetylcholine, a neurotransmitter, and unrelated to the diagnosis of Hirschsprung disease.
D. Serotonin (5-hydroxytryptamine or 5-HT) is a neurotransmitter involved in various physiological processes but is not a specific marker for Hirschsprung disease diagnosis.

**Clinical Pearl:**
Early diagnosis of Hirschsprung disease allows for appropriate management options, such as medical treatment with enemas or surgical intervention (pull-through procedure) to improve the patient's quality of life and prevent complications like megacolon and volvulus.

**Correct Answer:**
A. Chromogranin A (CgA) is the correct answer because it is a reliable marker for Hirschsprung disease diagnosis. Elevated serum CgA levels in HD patients can indicate the presence of aganglionic colon, enabling early diagnosis and timely intervention.